Fernan, Juliet C.
HRN: 22-29-82 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/14/2022
CEFUROXIME 750MG (VIAL)
12/14/2022
12/21/2022
IV
750mg
Q8h
For Orif
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Dose Wrong Dose
Overall appropriateness: No Wrong Dose